Zoe (Chi-Hsiu) Liu, et al. A Mutation-independent CRISPR/Cas9-based ‘Knockout and Replace’ Strategy to Treat Rhodopsin-associated Autosomal Dominant Retinitis Pigmentosa (RHO-adRP). Presented at The American Society of Gene and Cell Therapy (ASGCT) Annual Meeting, May 16-19, 2022.